Wu, T., Hu, S., Sylfa, N., Liao, J., Raza, A., Chen, B., . . . Lu, M. (2025). Associations between paraoxonase-1 activity and therapeutic drug monitoring indicators in schizophrenia patients treated with olanzapine: A cross-sectional study. Journal of psychopharmacology (Oxford), 39(2), 141. https://doi.org/10.1177/02698811241311459
Chicago Style (17th ed.) CitationWu, Tzu-Hua, Shu-Chin Hu, Nailis Sylfa, Jiahn-Haur Liao, Ahmad Raza, Bi-Li Chen, Chun-Hsin Chen, and Mong-Liang Lu. "Associations Between Paraoxonase-1 Activity and Therapeutic Drug Monitoring Indicators in Schizophrenia Patients Treated with Olanzapine: A Cross-sectional Study." Journal of Psychopharmacology (Oxford) 39, no. 2 (2025): 141. https://doi.org/10.1177/02698811241311459.
MLA (9th ed.) CitationWu, Tzu-Hua, et al. "Associations Between Paraoxonase-1 Activity and Therapeutic Drug Monitoring Indicators in Schizophrenia Patients Treated with Olanzapine: A Cross-sectional Study." Journal of Psychopharmacology (Oxford), vol. 39, no. 2, 2025, p. 141, https://doi.org/10.1177/02698811241311459.